McNeil Children's Motrin Combination Suspension Creates New Category
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Healthcare has received the go-ahead to launch the first ibuprofen/pseudoephedrine OTC pediatric product following FDA's approval of its NDA for Children's Motrin Cold Suspension Aug. 1.